VANTAGE CONSULTING GROUP INC
Q1 2022 Form 13-F

VIRGINIA BEACH, VIRGINIA
CIK 0001843547 · CRD 105240 · SEC-registered investment adviser
$256.3M Reported Value Total

VANTAGE CONSULTING GROUP INC reports 18 total accounts under management (AUM). There are 18 discretionary accounts valued at $2,268,493,632, and 0 non-discretionary accounts.

Source: Form ADV filed * Note that certain holdings are exempt from Form 13-F reporting, so the AUM totals may be greater than the Form 13-F total.
SEC Registered Discretionary Manager
Private funds (Form ADV)
14 funds · $325.3M gross asset value
Private Equity Fund: $192.2M · Hedge Fund: $68.5M · Other: $62.5M · Venture Capital Fund: $2.1M
Source: Form ADV filed 2026-09-21
Reported value
$256.3M
Quarter over quarter
-4.7%
Holdings
215
Top-10 concentration
75.1%

Filing Structure

Reports holdings for

Key People

Form ADV owners & control persons
Mark Terrence Finn
CHAIRMAN/CEO/CHIEF COMPLIANCE OFFICER
Jonathan Frederick Finn
EXECUTIVE VICE PRESIDENT/CIO
Eloise Clyde Chandler
PRESIDENT

Filing Navigation

13F Metrics

Loading 13F Metrics

Q1 2022 13F record

Q1 2022 13F filing summary

Q1 2022 Form 13F portfolio summary
Period of report March 31, 2022
Filed May 16, 2022
Form 13F-HR
Reported value $256.3M
Positions 215
Change in reported value -31.1%
New positions 6
Exited positions 22
Position turnover 11.8%
Top-10 concentration 75.1%

13F filings by quarter

Form 13F filings by quarter
Quarter Positions Value
Q4 2025 13F
Filed Feb 11, 2026
3 $19.7M
Q3 2025 13F
Filed Nov 6, 2025
3 $11.2M
Q2 2025 13F
Filed Aug 12, 2025
3 $5.7M
Q1 2025 13F
Filed May 9, 2025
4 $5.0M
Q4 2024 13F
Filed Feb 12, 2025
5 $10.5M
Q3 2024 13F
Filed Nov 14, 2024
4 $11.4M
Q2 2024 13F
Filed Aug 14, 2024
191 $134.6M
Q1 2024 13F
Filed May 15, 2024
212 $157.3M
Q4 2023 13F
Filed Feb 14, 2024
208 $148.8M
Q3 2023 13F
Filed Nov 14, 2023
200 $149.2M
Q2 2023 13F
Filed Aug 11, 2023
216 $173.9M
Q1 2023 13F
Filed May 10, 2023
231 $176.1M
Q4 2022 13F
Filed Feb 13, 2023
212 $169.4M
Q3 2022 13F
Filed Nov 14, 2022
213 $171.2M
Q2 2022 13F
Filed Aug 9, 2022
213 $178.3M
Q1 2022 13F
Filed May 16, 2022
215 $256.3M
Q4 2021 13F
Filed Feb 14, 2022
231 $372.0M
Q3 2021 13F
Filed Nov 10, 2021
206 $467.0M
Q2 2021 13F
Filed Aug 11, 2021
211 $574.8M
Q1 2021 13F
Filed May 14, 2021
99 $498.2M

1 earlier quarter on file — choose one from the quarter menu above.

Top 20 holdings · Q1 2022

Largest Q1 2022 13F positions by reported value
# Holding Reported value % of portfolio
1 RPRX Royalty Pharma Plc. $106.3M 41.47%
2 SSPY Syntax Stratified LargeCap ETF $43.6M 17.03%
3 ADCT ADC Therapeutics SA $24.7M 9.63%
4 FGEN Fibrogen, Inc $7.3M 2.84%
5 SMDY Syntax Straified MidCap ETF $5.1M 1.98%
6 SSLY Syntax Straified SmallCap ETF $2.5M 0.98%
7 COST Costco Wholesale Corporation $799.0K 0.31%
8 SYY Sysco Corporation $768.0K 0.3%
9 WMT Walmart Inc $767.0K 0.3%
10 KR Kroger Co. $751.0K 0.29%
11 MSFT Microsoft Corporation $716.0K 0.28%
12 XOM Exxon Mobil Corporation $712.0K 0.28%
13 CVX Chevron Corporation $697.0K 0.27%
14 CVS CVS Health Corporation $636.0K 0.25%
15 WBA Walgreens Boots Alliance Inc $614.0K 0.24%
16 AAPL Apple Inc $551.0K 0.22%
17 VLO Valero Energy Corporation $540.0K 0.21%
18 SBUX Starbucks Corporation $536.0K 0.21%
19 MSI Motorola Solutions Inc $533.0K 0.21%
20 MPC Marathon Petroleum Corporation $531.0K 0.21%

Values as reported on the Q1 2022 Form 13F. Every position is in the holdings table below.

Filing Details

Loading Activities
Loading Sector Allocation
Crunching numbers

Performance

Loading Performance

Potential New Buys

Finding Potential New Buys

Holdings

Building table
Loading SEC filing data
Loading Form 4 Filings

Beneficial Ownership (Schedule 13D/13G)

Loading 13D/G filings